Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Blind and Positive Control Design: a Phase III Clinical Trial to Evaluate the Consistency Between Batches of 5 Doses of Freeze-dried Rabies Vaccine (Vero Cell) and the Immunogenicity and Safety of 4 Doses of Vaccine (1-1-1-1)

NCT05545371 is registered in ClinicalTrials.gov with Changchun Zhuoyi Biological Co., Ltd as lead sponsor.

NCT NCT05545371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05545371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Blind and Positive Control Design: a Phase III Clinical Trial to Evaluate the Consistency Between Batches of 5 Doses of Freeze-dried Rabies Vaccine (Vero Cell) and the Immunogenicity and Safety of 4 Doses of Vaccine (1-1-1-1)
Lead sponsor
Changchun Zhuoyi Biological Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
June 18, 2022
Completion date
August 14, 2023
Enrollment
2,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody, rabies human